RESEARCH ARTICLE


Preface by the Editor



Arpad Szallasi*
Monmouth Medical Center, Long Branch, NJ, USA.


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 528
Abstract HTML Views: 534
PDF Downloads: 303
Total Views/Downloads: 1365
Unique Statistics:

Full-Text HTML Views: 286
Abstract HTML Views: 313
PDF Downloads: 209
Total Views/Downloads: 808



Creative Commons License
© 2013 Arpad Szallasi .

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Monmouth Medical Center, Long Branch, NJ, USA; Tel: 410-706-4452; E-mail: ASzallasi@barnabashealth.org


Abstract

With over 600 reviews, Transient Receptor Potential (TRP) channels arguably represent today’s most extensively reviewed pharmacological targets. The literature on TRP channels is vast and still growing: it has exploded from a mere 21 papers in 1995 to over 2,000 in the past two years. In the past fifteen years, the field had shown spectacular progress. From the cloning of the vanilloid (capsaicin) recep a novel class of analgesic agents.tor TRPV1 in 1997 it has taken only a decade for the first small molecule TRPV1 antagonists to enter clinical trials as

So why to add another review collection to this already overwhelming body of literature? First, new therapeutic tar-gets are emerging (e.g. TRPA1 and TRPV3) that look even more promising than TRPV1. Second, even the most studied TRP channel, TRPV1, continues to surprise. One might ar-gue that we are still at the beginning of the long and arduous road to obtain clinically useful analgesic drugs targeting TRP channels. It remains to be discovered if TRP channels are really Targets for Pain Relief, but it has already been clear that Bernd Nilius was right in calling TRP channels “Truly Remarkable Proteins.”